Blog

| Fatty liver | News | Treatments

Efficacy of resmetirom in clinical practice and side effects

Resmetirom is the first approved drug for steatohepatitis, effective in reducing liver fat and fibrosis. Available in the U.S., it awaits approval in Europe due to high cost and limited access.

| Fatty liver | News | Treatments

Efimosfermin-alfa: New drug for fatty liver

Efimosfermin-alfa shows promise as a treatment for fatty liver disease, improving fibrosis and inflammation with monthly dosing, according to early clinical study results.

| Diseases | News | Treatments

Benefits of statins for liver diseases

A JAMA study shows that statins may benefit liver disease patients by lowering liver cancer risk, reducing complications, and improving fibrosis, especially with lipophilic and hydrophilic statins.

| Diseases | Fatty liver | Healthy nutrition

Fatty liver disease prevention

Fatty liver disease prevention involves healthy diets, intermittent fasting, regular exercise, coffee intake, and limiting sugars and saturated fats. These actions help reduce liver fat and disease risk.

| Fatty liver | News

Relationship between fatty liver and kidney and gallbladder stones

Research indicates a potential relationship between fatty liver, kidney stones, and gallstones due to shared metabolic risk factors. More studies are required to validate these findings across different populations.

| Fatty liver | News | Treatments

Curcumin: food supplement for the treatment of fatty liver

Studies suggest that curcumin for fatty liver improves liver enzyme levels, reduces fibrosis, and has cardiovascular benefits. Although promising, more extensive trials are needed to validate its effectiveness as a long-term treatment option.

| Autoinmune hepatitis | Diagnosis | Diagnósticos | Diseases | Enfermedades

Autoimmune hepatitis, is it difficult to diagnose?

Autoimmune liver disease occurs when the immune system attacks the liver, leading to inflammation and damage. Although its cause is unclear, viruses, vaccines, and antibiotics may trigger it. Early diagnosis is essential to managing and treating this potentially severe condition.

| News | Treatments

New treatment for primary biliary cholangitis

Primary biliary cholangitis is a rare liver disease causing bile duct damage. New therapies like seladelpar improve outcomes for treatment-resistant patients, offering better symptom management.